Detalhe da pesquisa
1.
Mutant KRAS modulates colorectal cancer cells invasive response to fibroblast-secreted factors through the HGF/C-MET axis.
Int J Cancer
; 151(10): 1810-1823, 2022 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869872
2.
The mechanism of sitagliptin inhibition of colorectal cancer cell lines' metastatic functionalities.
IUBMB Life
; 73(5): 761-773, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33615655
3.
S100P is a molecular determinant of E-cadherin function in gastric cancer.
Cell Commun Signal
; 17(1): 155, 2019 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31767037
4.
Dissecting the signaling pathways associated with the oncogenic activity of MLK3 P252H mutation.
BMC Cancer
; 14: 182, 2014 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24628919
5.
Analytical Techniques for Characterizing Tumor-Targeted Antibody-Functionalized Nanoparticles.
Life (Basel)
; 14(4)2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38672759
6.
KRAS silencing alters chromatin physical organization and transcriptional activity in colorectal cancer cells.
Res Sq
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38410476
7.
Lipid Nanoparticles Functionalized with Antibodies for Anticancer Drug Therapy.
Pharmaceutics
; 15(1)2023 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36678845
8.
Injectable Poloxamer Hydrogels for Local Cancer Therapy.
Gels
; 9(7)2023 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37504472
9.
Mixed lineage kinase 3 gene mutations in mismatch repair deficient gastrointestinal tumours.
Hum Mol Genet
; 19(4): 697-706, 2010 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19955118
10.
Regulation of homeostasis and oncogenesis in the intestinal epithelium by Ras.
Exp Cell Res
; 317(19): 2732-9, 2011 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21741971
11.
Modulation of Fibroblast Phenotype by Colorectal Cancer Cell-Secreted Factors Is Mostly Independent of Oncogenic KRAS.
Cells
; 11(16)2022 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36010567
12.
Mutant KRAS-Associated Proteome Is Mainly Controlled by Exogenous Factors.
Cells
; 11(13)2022 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35805073
13.
Decellularized Colorectal Cancer Matrices as Bioactive Scaffolds for Studying Tumor-Stroma Interactions.
Cancers (Basel)
; 14(2)2022 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35053521
14.
Stimuli-responsive hydrogels for intratumoral drug delivery.
Drug Discov Today
; 26(10): 2397-2405, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33892147
15.
The immunosuppressive and pro-tumor functions of CCL18 at the tumor microenvironment.
Cytokine Growth Factor Rev
; 60: 107-119, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33863622
16.
B-Raf(V600E) cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival.
Gastroenterology
; 135(3): 899-906, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18602919
17.
Targeting the Tumor Microenvironment: An Unexplored Strategy for Mutant KRAS Tumors.
Cancers (Basel)
; 11(12)2019 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31847096
18.
BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?
BMC Cancer
; 8: 255, 2008 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-18782444
19.
Tumour selection advantage of non-dominant negative P53 mutations in homozygotic MDM2-SNP309 colorectal cancer cells.
J Med Genet
; 44(1): 75-80, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16825434
20.
KRAS Oncogenic Signaling Extends beyond Cancer Cells to Orchestrate the Microenvironment.
Cancer Res
; 78(1): 7-14, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29263151